Identifying Gaps in Real-World Management of Diabetes in Nigeria: A Subset Analysis of Cross-Sectional Wave-7 Data from the International Diabetes Management Practices Study

作     者：Babatope A. Kolawole Felicia A. Anumah Chioma Unachukwu Babatope A. Kolawole;Felicia A. Anumah;Chioma Unachukwu

作者机构：Endocrinology Unit Department of Medicine Obafemi Awolowo University Teaching Hospital Ile-Ife Nigeria Endocrinology Unit Department of Medicine University of Abuja Teaching Hospital Abuja Nigeria Endocrinology Unit Department of Medicine University of Port Harcourt Teaching Hospital Port-Harcourt Nigeria 

出 版 物：《Journal of Diabetes Mellitus》 (糖尿病（英文）)

年 卷 期：2022年第12卷第4期

页      面：284-301页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Diabetes Management Gaps Nigeria 

摘      要：Background/Purpose: Poor glycemic control in Nigeria necessitates assessment and standardization of diabetes care. This study aimed to assess real-world management of people with type 2 diabetes mellitus (T2DM) and type 1 diabetes mellitus (T1DM) in Nigeria. Methods: This cross-sectional phase of the seventh wave of International Diabetes Management Practices Study, conducted between 22nd August and 30th September 2016, included adults with T1DM or T2DM during a two-week recruitment period. Results: Of 304 people with T2DM, 187 received oral glucose lowering drugs (OGLDs) only;88 received OGLDs + insulin;27 received insulin only. Metformin + sulfonylureas (128/187;68.45%) and premix only (76/115;66.09%) were the most used OGLD and insulin regimens respectively. Of 77 people with TIDM, all received insulin;six (7.79%) received OGLDs. Insulin initiation was noted around five years after diabetes diagnosis in T2DM (diabetes duration: 8.69 + 7.16 years;duration of insulin treatment: 3.17 ± 4.49 years). Proportion of people achieving glycemic targets (HbA1c Conclusion: Early insulinization and subsidized healthcare can improve long-term diabetes outcomes in Nigeria.